Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fischer, Dominik
NCT02610582: Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia	Active, not recruiting	1/2	13	Europe	rAAV.hCNGA3	STZ eyetrial, University Hospital Tuebingen, Ludwig-Maximilians - University of Munich	Achromatopsia	06/27	06/27
Pigment, NCT04611503: PDE6A Gene Therapy for Retinitis osa	Active, not recruiting	1/2	9	Europe	subretinal injection of rAAV.hPDE6A, Gene therapy	STZ eyetrial	Retinitis Pigmentosa	07/27	07/27
Fischer, Manuel D
NCT02610582: Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia	Active, not recruiting	1/2	13	Europe	rAAV.hCNGA3	STZ eyetrial, University Hospital Tuebingen, Ludwig-Maximilians - University of Munich	Achromatopsia	06/27	06/27